Abstract
The goal of this study was to determine the prevalence of fluoroquinolone resistance in Streptococcus agalactiae and the serotype distribution of this resistant bacterium. S. agalactiae strains collected from 221 asymptomatic pregnant women (35–37 weeks of gestation) and 838 patients with S. agalactiae infection in Korea, from 2006 to 2008, were tested for susceptibility to four fluoroquinolones. Rates of resistance of S. agalactiae to ciprofloxacin, levofloxacin, and moxifloxacin were 9.3 %, 9.5 %, and 0.8 %, respectively; greater than 94 % of S. agalactiae strains were resistant to norfloxacin. Resistance to ciprofloxacin and levofloxacin increased between 2006 and 2008. All strains were susceptible to penicillin. Resistance to ciprofloxacin and levofloxacin was higher in the clinical strains of S. agalactiae isolated from infections than in colonizing strains isolated from pregnant women. Mutations in the quinolone resistance-determining regions of gyrase and topoisomerase genes were detected in strains resistant to ciprofloxacin, levofloxacin, and moxifloxacin; no such mutations were found in strains resistant only to norfloxacin. There was a strong correlation between the minimum inhibitory concentrations and the presence of mutations in gyrase and topoisomerase genes. In conclusion, the prevalence of fluoroquinolone resistance was unexpectedly high. Strain serotypes were not associated with susceptibility to fluoroquinolones.
Similar content being viewed by others
References
Gibbs RS, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104(5 Pt 1):1062–1076. doi:10.1097/01.AOG.0000144128.03913.c2
Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, Oh KY, Yoon HR, Pai SY, Foxman B, Ki M (2010) Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 138(2):292–298. doi:10.1017/S0950268809990859
Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC (1997) Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis 16(10):753–756
Kim M, Jang H, Chang D, Cho J, Kim Y, Choi H, Kim S, Lee J, Hwang K, Kang B (2006) Group B streptococcal colonization rate in Korean pregnant women. Korean J Obstet Gynecol 49(2):337–344
Choi K, Koh S, Lee J, Park J, Hwang S, Lee B, Lee W (2002) Clinical significance of group B streptococcal infection in pregnant women. Korean J Obstet Gynecol 45(5):811–815
Lee J, Kim S, Lee H, Kim S, Choi S, Sung I, Kang J, Chun C (2003) A clinical study of group B streptococcal infection: five years experience. J Korean Soc Neonatol 10(2):226–234
Scheld WM (2003) Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9(1):1–9
Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2(9):530–538
Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T (2003) First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 47(11):3605–3609
Biedenbach DJ, Toleman MA, Walsh TR, Jones RN (2006) Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 55(2):119–127
Wu HM, Janapatla RP, Ho YR, Hung KH, Wu CW, Yan JJ, Wu JJ (2008) Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 52(5):1888–1890
von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R (2003) A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol 41(5):2166–2169
Ulett KB, Benjamin WH Jr, Zhuo F, Xiao M, Kong F, Gilbert GL, Schembri MA, Ulett GC (2009) Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol 47(7):2055–2060. doi:10.1128/JCM.00154-09
Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, Doern GV (2000) Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 183(4):859–862. doi:10.1067/mob.2000.108839
Brueggemann AB, Coffman SL, Rhomberg P, Huynh H, Almer L, Nilius A, Flamm R, Doern GV (2002) Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother 46(3):680–688
Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, Yang JH, Yoon HR, Miller B, DeBusscher J, Foxman B, Ki M (2010) Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci 25(6):817–823. doi:10.3346/jkms.2010.25.6.817
National Committee for Clinical Laboratory Standards (NCCLS) (2002) Performance Standards for Antimicrobial Susceptibility Testing, vol M100–S12. Table 2 H. Wayne, PA, USA
Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF (2004) Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 42(1):146–150
Zhang L, Reddi U, Srinivasan U, Li S, Borchardt SM, Pillai P, Mehta P, Styka AN, Debusscher J, Marrs CF, Foxman B (2008) Combining microarray technology and molecular epidemiology to identify genes associated with invasive group B streptococcus. Interdiscip Perspect Infect Dis 2008(314762):1–10. doi:10.1155/2008/314762
Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B (2004) Library on a slide for bacterial comparative genomics. BMC Microbiol 4:12. doi:10.1186/1471-2180-4-12
Marrs CF, Zhang L, Tallman P, Manning SD, Somsel P, Raz P, Colodner R, Jantunen ME, Siitonen A, Saxen H, Foxman B (2002) Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol 51(2):138–142
Harris TO, Shelver DW, Bohnsack JF, Rubens CE (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111(1):61–70. doi:10.1172/JCI16270
Bhavnani SM, Hammel JP, Jones RN, Ambrose PG (2005) Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 51(1):31–37
Tazi A, Gueudet T, Varon E, Gilly L, Trieu-Cuot P, Poyart C (2008) Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis 14(2):349–350
Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, Segal-Maurer S, Tommasulo B, Drlica K, Urban C, Rahal JJ (2005) Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob Agents Chemother 49(6):2495–2497
Fuller JD, Low DE (2005) A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 41(1):118–121. doi:10.1086/430829
Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP (2004) Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 48(9):3491–3497. doi:10.1128/AAC.48.9.3491-3497.2004
Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev: MMBR 61(3):377–392
Pestova E, Millichap JJ, Noskin GA, Peterson LR (2000) Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother 45(5):583–590
Takei M, Fukuda H, Kishii R, Hosaka M (2001) Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45(12):3544–3547. doi:10.1128/AAC.45.12.3544-3547.2001
Baranova NN, Neyfakh AA (1997) Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 41(6):1396–1398
Jumbe NL, Louie A, Miller MH, Liu W, Deziel MR, Tam VH, Bachhawat R, Drusano GL (2006) Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 50(1):310–317. doi:10.1128/AAC.50.1.310-317.2006
Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19(2):382–402. doi:10.1128/CMR.19.2.382-402.2006
Tran JH, Jacoby GA, Hooper DC (2005) Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49(1):118–125
Rodriguez-Martinez JM, Velasco C, Briales A, Garcia I, Conejo MC, Pascual A (2008) Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother 61(6):1240–1243. doi:10.1093/jac/dkn115
Ince D, Hooper DC (2003) Quinolone resistance due to reduced target enzyme expression. J Bacteriol 185(23):6883–6892
Acknowledgments
We thank the Seoul Clinical Laboratories, the Seoul Medical Science Institute, and the following physicians for providing some of the isolates used in this study: Jung Yeol Han, Hyun-Mi Ryu, and Hyun-Kyong Ahn (Cheil General Hospital & Women's Healthcare Center, Kwandong University, Seoul); In-Tack Hwang and Jung-Hun Rho (Eulji University Hospital, Daejeon); and Seo-Yoo Hong and Won-Il Park (Eulji Hospital, Seoul). This work was supported by a Korea Research Foundation Grant funded by the Korean Government (KRF-2009-0074540).
Conflict of interest
All authors claim no commercial or other association that might pose a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ki, M., Srinivasan, U., Oh, K.Y. et al. Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea. Eur J Clin Microbiol Infect Dis 31, 3199–3205 (2012). https://doi.org/10.1007/s10096-012-1685-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1685-8